Delivery Order SPE2DB24D6044-SPE2DB25FLJLH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,148.12 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count) with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,263.91 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $2,004.58 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 10 mg capsules (100-count package). This competitively awarded, firm fixed-price delivery order was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. The order carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,148.65. This non-competitive, firm fixed-price delivery order is set to conclude on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,169.62 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 10 mg capsules (100 count). The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,891.34 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100 count). The contract is firm fixed price with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child delivery order under a larger contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,135,189 units of Dexmethylphenidate ER 10 mg capsules. The $2,805.96 contract has an ultimate completion date of April 2, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its corporate office located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,143.20 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 25 mg capsules (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. This competitive, non-set-aside delivery order utilizes firm fixed price terms and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,606.41. This is a firm fixed-price delivery order with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,550.88. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJLHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,605.70 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count). This competitively awarded contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs globally, including specialty pharmaceuticals, generic and brand-name drugs, vaccines, and related medical commodities. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative plans multiple regional awards across several contractors, positioning AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/3/25 |